Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

Skye Bioscience reports Phase 2a data showing nimacimab plus semaglutide led to over 22% weight loss at 52 weeks, with lower ...

Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...

Skye Bioscience has published 52-week data on its investigational obesity drug combination, linking the cocktail to 22.3% ...

The oral weight-loss drug introduced by Novo Nordisk this year in the U.S. is quickly being adopted.

The cost of weight loss drug Wegovy will soon be massively subsidised for Australians with severe obesity who have had a stroke or heart attack.

NEW YORK — A new pill form of the weight-loss drug Wegovy is now available to people in the United States, giving adults a daily tablet option instead of a weekly injection, health officials and the ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight.

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk's shares plunged as much as 20% ...

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...